Pioneering IVF/Femtech Diagnostics.

Mireya Dx cutting-edge Medical Analytical Diagnostic Company. 

Mireya DX is a pioneering company in the realm of IVF/FeMtech diagnostics, where we have dedicated over 8 years to research and development to push the boundaries of reproductive technology. Our aim is to transform the IVF experience for couples and individuals seeking fertility solutions.

Mireya Dx is a cutting-edge Medical Analytical Diagnostic Company. We specialize in Clinical Diagnostic Testing and hold patents primarily for utilizing Matrix-assisted Laser Desorption Ionization (MALDI) time-of-flight mass spectrometry in direct clinical sample analysis, as well as multi-analyte mass analysis with minimal preparative processing. Our innovative approach also leverages Artificial Intelligence (AI) and Machine Learning for spectral analysis, enabling disease-specific pattern recognition of mass spectra and data processing algorithms for precise biomarker identification and quantitation.

Our pioneering technology finds its initial application in the global IVF and fertility sectors, promising to enhance diagnostic capabilities and patient outcomes. We’re dedicated to making a significant impact through innovation and precision.

We have proudly patented the Revolutionary BESST Test.

The BESST Test is a complementary test for Embryo Selection that will make an impact across all age profiles who are trying to conceive through IVF.